SITE MAP   |   CONTACT US


   More
24.01 25.26
up0.16
0.67%
up0.13
0.51%
As of: 02/09/10 02/09/10
 
10271.14 11898.69
up1.67
+0.02%
up51.72
+0.43%
As of: 02/09/10 02/09/10

Stock Chart
Note: The stock price performance shown on the quote above is not necessarily indicative of the future price performance

Copyright © 1998-2002 MarketWatch.com Inc. User agreement applies. Historical and current end-of-day data provided by Interactive Data Corp. Intraday data is at least 20-minutes delayed. All times are EDT. Intraday data provided by S&P Comstock and subject to terms of use.


Tools

Investment Calculator


Email Alerts

Resources

Q2 2010 Financial Results

Valeant - Biovail Analyst Investor Presentation

Biovail - Valeant Merger Conference Call

Biovail's Product Pipeline

Pimavanserin Schizophrenia Co-Therapy - Phase 2 Data

Aplenzin Prescribing Information

Nitoman Prescribing Information

Xenazine Prescribing Information

Xenazine Medication Guide

Corporate Fact Sheet

IMPORTANT: Income Tax Information for Canadian Resident Shareholders


Download Adobe Acrobat Reader

Events




© 2007 Biovail Corporation - All Rights Reserved (BIO113B0602) Privacy Policy   |   Disclaimers